Amarin Corp. Plc, a biopharmaceutical company, specializes in developing and commercializing therapeutics aimed at enhancing cardiovascular health, primarily through its lead product, Vascepa. Vascepa, used to lower triglyceride levels in adults with severe hypertriglyceridemia, is distributed mainly to wholesalers and pharmacies.
Aaron Berg bought 160,000 shares of AMRN on 2 August at $0.64 per share, worth a total of $102K. They now own 805,380 AMRN shares, or a 25% holding increase.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
